|
|
| | 5-Bromo-2-nitro-3-Pyridinol Basic information |
| Product Name: | 5-Bromo-2-nitro-3-Pyridinol | | Synonyms: | 5-Bromo-2-nitro-3-Pyridinol;5-BroMo-2-nitropyridin-3-ol;5-BroMo-3-hydroxy-2-nitropyridine;3-Pyridinol, 5-bromo-2-nitro-;5 - bromo - 2 - nitro - 3 - hydroxypyridine;5-Bromo-2-nitro-3-Pyridinol ISO 9001：2015 REACH;Ethanone,1-(2-pyridinyl)-2-(5-quinolinyl)-;1H-Benzimidazole-1-acetonitrile,2,3-dihydro-3-oxo- | | CAS: | 691872-15-8 | | MF: | C5H3BrN2O3 | | MW: | 218.99 | | EINECS: | | | Product Categories: | | | Mol File: | 691872-15-8.mol |  |
| | 5-Bromo-2-nitro-3-Pyridinol Chemical Properties |
| Boiling point | 393.4±37.0 °C(Predicted) | | density | 2.006±0.06 g/cm3(Predicted) | | storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | pka | -1.63±0.10(Predicted) |
| | 5-Bromo-2-nitro-3-Pyridinol Usage And Synthesis |
| Uses | 5-Bromo-3-hydroxy-2-nitropyridine was used to design potent and selective inhibitors to overcome clinical anaplastic Lymphoma kinase mutations resistant to Crizotinib (C785000), a potential antitumor agent. |
| | 5-Bromo-2-nitro-3-Pyridinol Preparation Products And Raw materials |
|